{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:01:28Z","timestamp":1785884488207,"version":"3.56.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00246-010-9790-x","type":"journal-article","created":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T03:49:52Z","timestamp":1285818592000},"page":"1198-1202","source":"Crossref","is-referenced-by-count":14,"title":["Do Predictors Exist for a Successful Withdrawal of Preoperative Prostaglandin E1 from Neonates with d-Transposition of the Great Arteries and Intact Ventricular Septum?"],"prefix":"10.1007","volume":"31","author":[{"given":"Angela","family":"Oxenius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja I.","family":"Hug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Dodge-Khatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cavigelli-Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Bauersfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Balmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,1]]},"reference":[{"key":"9790_CR1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0735-1097(92)90288-X","volume":"19","author":"BG Baylen","year":"1992","unstructured":"Baylen BG, Grzeszczak M, Gleason ME (1992) Role of balloon atrial septostomy before early arterial switch repair of transposition of the great arteries. J Am Coll Cardiol 19:1025\u20131031","journal-title":"J Am Coll Cardiol"},{"key":"9790_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00561482","volume":"18","author":"F Coceani","year":"1980","unstructured":"Coceani F, Olley PM, Lock JE (1980) Prostaglandins, ductus arteriosus, pulmonary circulation: current concepts and clinical potential. Eur J Clin Pharmacol 18:75\u201381","journal-title":"Eur J Clin Pharmacol"},{"key":"9790_CR3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/jp.2008.11","volume":"28","author":"E Finan","year":"2008","unstructured":"Finan E, Mak W, Bismilla Z, McNamara PJ (2008) Early discontinuation of intravenous prostaglandin E1 after balloon atrial septostomy is associated with an increased risk of rebound hypoxemia. J Perinatol 28:341\u2013346","journal-title":"J Perinatol"},{"key":"9790_CR4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0167-5273(88)90076-9","volume":"19","author":"AC Gittenberger-de Groot","year":"1988","unstructured":"Gittenberger-de Groot AC, Strengers JL (1988) Histopathology of the arterial duct (ductus arteriosus) with and without treatment with prostaglandin E1. Int J Cardiol 19:153\u2013166","journal-title":"Int J Cardiol"},{"key":"9790_CR5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/j.1875-9114.1982.tb04522.x","volume":"2","author":"MA Heymann","year":"1982","unstructured":"Heymann MA, Clyman RI (1982) Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy. Pharmacotherapy 2:148\u2013155","journal-title":"Pharmacotherapy"},{"key":"9790_CR6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/106002809603000311","volume":"30","author":"MB Kaufman","year":"1996","unstructured":"Kaufman MB, El-Chaar GM (1996) Bone and tissue changes following prostaglandin therapy in neonates. Ann Pharmacother 30:269\u2013274, 277","journal-title":"Ann Pharmacother"},{"key":"9790_CR7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.CIR.64.5.893","volume":"64","author":"AB Lewis","year":"1981","unstructured":"Lewis AB, Freed MD, Heymann MA, Roehl SL, Kensey RC (1981) Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 64:893\u2013898","journal-title":"Circulation"},{"key":"9790_CR8","first-page":"524","volume":"98","author":"H Lucron","year":"2005","unstructured":"Lucron H, Chipaux M, Bosser G (2005) Complications of prostaglandin E1 treatment of congenital heart disease in paediatric medical intensive care. Arch Mal Coeur Vaiss 98:524\u2013530","journal-title":"Arch Mal Coeur Vaiss"},{"key":"9790_CR9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1620\/tjem.146.237","volume":"146","author":"T Ohara","year":"1985","unstructured":"Ohara T, Ogata H, Fujiyama J (1985) Effects of prostaglandin E1 infusion in the preoperative management of critical congenital heart disease. Tohoku J Exp Med 146:237\u2013249","journal-title":"Tohoku J Exp Med"},{"key":"9790_CR10","first-page":"1063","volume":"35","author":"A Saxena","year":"1998","unstructured":"Saxena A, Sharma M, Kothari SS (1998) Prostaglandin E1 in infants with congenital heart disease: Indian experience. Indian Pediatr 35:1063\u20131069","journal-title":"Indian Pediatr"},{"key":"9790_CR11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/eurheartj\/15.suppl_3.377","volume":"15","author":"GK Singh","year":"1994","unstructured":"Singh GK, Fong LV, Salmon AP, Keeton BR (1994) Study of low-dosage prostaglandin usages and complications. Eur Heart J 15:377\u2013381","journal-title":"Eur Heart J"},{"key":"9790_CR12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00716473","volume":"146","author":"BD Thanopoulos","year":"1987","unstructured":"Thanopoulos BD, Andreou A, Frimas C (1987) Prostaglandin E2 administration in infants with ductus-dependent cyanotic congenital heart disease. Eur J Pediatr 146:279\u2013282","journal-title":"Eur J Pediatr"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-010-9790-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-010-9790-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-010-9790-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T10:12:06Z","timestamp":1558692726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-010-9790-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,1]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["9790"],"URL":"https:\/\/doi.org\/10.1007\/s00246-010-9790-x","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,1]]}}}